SCHEMBL1743686

SCHEMBL1743686

NC(N)=NCCCC(=O)O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.52
NFKB1 P19838 3/20 0.52
TSHR P16473 3/20 0.52
GLA P06280 1/20 0.52
APEX1 P27695 1/20 0.52
CYP2C19 P33261 1/20 0.52
NOS2 P35228 1/20 0.52
ALOX15 P16050 1/20 0.48
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
LMNA P02545 3/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
CPN1 P15169 1/20 0.47
CPB2 Q96IY4 1/20 0.47
DHPS P49366 1/20 0.46
BLM P54132 2/20 0.46
GABRR3 A8MPY1 1/20 0.46
GABRP O00591 1/20 0.46
GABRD O14764 1/20 0.46
HDAC3 O15379 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4670166 0.93 CHRM2 (0.53) CYP1A2NFKB1TSHRGLAAPEX1
SCHEMBL5541512 0.91 CHRM2 (0.56) CYP1A2NFKB1TSHRALOX15MAOA
Ompenaclid SCHEMBL66712 0.84
Tiformin SCHEMBL1736430 0.84 CYP1A2 (0.52) CYP1A2NFKB1TSHRGLAAPEX1
SCHEMBL1735347 0.81 CYP1A2 (0.48) CYP1A2NFKB1TSHRGLAAPEX1
SCHEMBL31147718 0.77 CHRM2 (0.57) CYP1A2NFKB1TSHRGLAAPEX1
SCHEMBL17234583 0.75 KDM4E (0.43) CYP1A2NFKB1TSHRALOX15LMNA
SCHEMBL1736351 0.74 CYP1A2 (0.67) CYP1A2NFKB1ALOX15MAOAMAOB
Arcaine SCHEMBL1737639 0.74 CYP1A2 (0.77) CYP1A2NFKB1ALOX15MAOAMAOB
SCHEMBL2309667 0.73 TSHR (0.65) NFKB1TSHRALOX15LMNASLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121512985-B Application of Slc36a1 agonist in preparation of medicines for preventing and/or treating colonitis 中国医学科学院医药生物技术研究所 2026-05-12 CN disclosed
US-20250288624-A1 LONG-TERM STABILIZATION, FORMULATION AND TABLETING OF LIVE MICROBIAL CELLS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-09-18 US disclosed
CN-117442594-A Use of compounds for diagnosis and treatment of novel coronavirus infections 厦门大学 2024-01-26 CN disclosed
EP-2387396-B1 AGENT FOR PREVENTING AND TREATING PITYRIASIS VERSICOLOR JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN (DE) 2017-11-15 EP disclosed
EP-2565646-B1 DIAGNOSTIC MARKER FOR KIDNEY DISEASES AND USE THEREOF SYSMEX CORP (JP) 2017-10-18 EP disclosed
US-8927221-B2 Diagnostic marker for kidney diseases and use thereof SYSMEX CORPORATION (JP) 2015-01-06 US disclosed
US-8927221-B2 Diagnostic marker for kidney diseases and use thereof SYSMEX CORPORATION (JP) 2015-01-06 US disclosed
US-8765712-B2 Agent for preventing and treating pityriasis versicolor JUSTUS-LIEBIG-UNIVERSITAET GIESSEN (DE) 2014-07-01 US disclosed
US-20130157252-A1 DIAGNOSTIC MARKER FOR KIDNEY DISEASES AND USE THEREOF HUMAN METABOLOME TECHNOLOGIES, INC. (JP) 2013-06-20 US disclosed
US-20130157252-A1 DIAGNOSTIC MARKER FOR KIDNEY DISEASES AND USE THEREOF HUMAN METABOLOME TECHNOLOGIES, INC. (JP) 2013-06-20 US disclosed
EP-2565646-A1 DIAGNOSTIC MARKER FOR KIDNEY DISEASES AND USE THEREOF Sysmex Corporation (JP) 2013-03-06 EP disclosed
US-20120129800-A1 Agent For Preventing And Treating Pityriasis Versicolor JUSTUS-LIEBIG-UNIVERSITAT GIESSEN (DE) 2012-05-24 US disclosed
EP-2387396-A1 AGENT FOR PREVENTING AND TREATING PITYRIASIS VERSICOLOR Justus-Liebig-Universität Gießen (DE) 2011-11-23 EP disclosed
US-8041481-B2 Power steering system and method of influencing the damping of a power steering system TRW AUTOMOTIVE GMBH (DE) 2011-10-18 US disclosed
WO-2010081849-A1 AGENT FOR PREVENTING AND TREATING PITYRIASIS VERSICOLOR JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN (DE) 2010-07-22 WO disclosed